Pharmaceuticals

Biosimilars Market: Global Opportunity Analysis and Industry Forecast, 2021-2031

The global biosimilars market was valued at $15.9 billion in 2021, and is projected to reach $143.6 billion by 2031, growing at a CAGR of 24.7% from 2022 to 2031.

Report Code : A00573 | Pages : 242 | Category : Life Sciences

Hereceptin Biosimilars Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Herceptin, also known as trastuzumab, is used as a medication for patients who suffer from cancer, which assists in controlling the growth and spread of cancer cells in ...

Report Code : A03075 | Category : Life Sciences

Biosimilar Monoclonal Antibody Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global biosimilar monoclonal antibody market was valued at $8.7 billion in 2022, and is projected to reach $64.7 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.

Report Code : A03330 | Pages : 293 | Category : Life Sciences

Biologics and Biosimilars Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Biologics therapeutics drugs are genetically engineered proteins derived from human genetic material. Biologics therapeutics contains sugars, proteins, or nucleic acids or complex combinations of these substances, or may ...

Report Code : A03701 | Category : Life Sciences

India Biosimilars and Follow-On Biologics Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code : A04501 | Category : Life Sciences

Canadian Biosimilar Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code : A04504 | Category : Life Sciences

Fusion Protein and Biosimilars Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

A fusion protein biosimilars have come out as a new modality, as an alternate of biologic products due to their high cost. The fusion protein biosimilars merge the ...

Report Code : A12017 | Category : Life Sciences

Insulin Biosimilars Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Biosimilars are biological products that have active properties that are similar to those of a previously licensed drug and have no clinically relevant differences in terms of safety and effectiveness.

Report Code : A14003 | Category : Life Sciences

North America Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

In North America Biosimilars Market segment, the Type segment is expected to register significant growth during the forecast period.

Report Code : * A31155 | Category : Life Sciences

U.S. Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

By end user, the U.S. Biosimilars Market market is bifurcated into various sectors, Of those, Type was the largest segment and captured considerable market share in 2021.

Report Code : * A31156 | Category : Life Sciences

Mexico Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

By end user, the Mexico Biosimilars Market market is bifurcated into various sectors, Of those, Type was the largest segment and captured considerable market share in 2021.

Report Code : * A31157 | Category : Life Sciences

Canada Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

Research study titled Canada Biosimilars Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.

Report Code : * A31158 | Category : Life Sciences

Europe Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

The current Europe Biosimilars Market is quantitatively analyzed from 2021 to 2031 to benchmark the financial competency.

Report Code : * A31159 | Category : Life Sciences

U.K. Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

Type segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the U.K. Biosimilars Market due to the outbreak of COVID-19.

Report Code : * A31160 | Category : Life Sciences

Germany Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. Type was the leading segment.

Report Code : * A31161 | Category : Life Sciences

France Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

The Type segment in France Biosimilars Market is expected to garner considerable share in terms of value and volume during the forecast period.

Report Code : * A31162 | Category : Life Sciences

Italy Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

Italy Biosimilars Market size is projected to increase at a lucrative rate during the forecast period. The Italy Biosimilars Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry.

Report Code : * A31163 | Category : Life Sciences

Spain Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

Spain Biosimilars Market is projected to experience high investment on various major technologies/product/services in Spain country by the end of 2031 owing to presence of key end user vertical adopting offerings at a faster pace.

Report Code : * A31164 | Category : Life Sciences

Asia-Pacific Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

Europe region a dominant position in 2031. The market size section covers country-level market size and forecast which also includes the COVID-19 impact.

Report Code : * A31165 | Category : Life Sciences

Australia Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

Australia Biosimilars Market size is projected to increase at a lucrative rate during the forecast period. The Australia Biosimilars Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry.

Report Code : * A31166 | Category : Life Sciences

Japan Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

The report focuses on the major industry players operating in the Japan Biosimilars Market and their relative market share. Type segment dominates the Japan Biosimilars Market and is expected to retain its dominance throughout the forecast period.

Report Code : * A31167 | Category : Life Sciences

India Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

The India Biosimilars Market study provides detailed analysis on major drivers, restraints, trends, opportunities, and key player strategies impacting overall performance of market throughout the forecast period.

Report Code : * A31168 | Category : Life Sciences

China Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

The China Biosimilars Market is expected to expand at a promising compound annual growth rate (CAGR) between 2022 to 2031. The China Biosimilars Market growth is attributed to various driving factors and revenue opportunities.

Report Code : * A31169 | Category : Life Sciences

South Korea Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

The South Korea Biosimilars Market report includes the Porter’s five forces analysis of the industry to understand the competitive scenario of the industry, and the role of each stakeholder in the value chain.

Report Code : * A31170 | Category : Life Sciences

LAMEA Biosimilars Market: Opportunity Analysis and Industry Forecast, 2021-2031

The LAMEA Biosimilars Market is expected to witness strong growth during the forecast period.

Report Code : * A31171 | Category : Life Sciences